Is this the next REA Group (ASX:REA)?
Daniel Ortisi
September 14, 2023
There really isn’t a “secret sauce” behind these stories –
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
There really isn’t a “secret sauce” behind these stories –
The Cochlear Limited (ASX: COH) share price bounced dramatically higher
The CSL Ltd (ASX:CSL) share price is up more than
ResMed CDI (ASX: RMD) shares are trading down about -11%
The CSL Limited (ASX: CSL) share price has fallen below
On The Australian Investors Podcast this week, Owen Rask and
The CSL Limited (ASX:CSL) share price is in focus as
Tim Lincoln is the co-founder of Lincoln Indicators. Tim Lincoln
The Resmed CDI (ASX:RMD) share price bounced 6.5% higher today
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
Here you go: A $50,000 per year passive income special report
Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.
Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.
Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.